0

Journal Articles

in Drug/Vaccine Safety
 41-60 of 90 Articles
Health Agencies Update |  June 27, 2012
Fingolimod Precautions
Bridget M. Kuehn
JAMA. 2012;307(24):2578. doi:10.1001/jama.2012.7064.
Medical News and Perspectives |  June 27, 2012
FDA and Pharma Seek Better Ways to Assess Drug Safety, Efficacy in Clinical Trials
Mike Mitka
JAMA. 2012;307(24):2576-2577. doi:10.1001/jama.2012.6684.
Viewpoint |  June 20, 2012
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions:  Opportunities Provided by a New IOM Report
Bruce M. Psaty, MD, PhD; Eric M. Meslin, PhD; Alasdair Breckenridge, MD, FRCP
JAMA. 2012;307(23):2491-2492. doi:10.1001/jama.2012.5545.
Medical News and Perspectives |  June 20, 2012
IOM Urges FDA to Be More Aggressive in Monitoring Safety of Approved Drugs
Bridget M. Kuehn
JAMA. 2012;307(23):2475-2476. doi:10.1001/jama.2012.5993.
Capitol Health Call |  June 13, 2012
Autism Research
Mike Mitka
JAMA. 2012;307(22):2362. doi:10.1001/jama.2012.6078.
Commentary |  October 12, 2011
Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety
Dima M. Qato, PharmD, MPH, PhD; G. Caleb Alexander, MD, MS
JAMA. 2011;306(14):1595-1596. doi:10.1001/jama.2011.1457.
Editorial |  August 24, 2011
Going Home on the Right Medications:  Prescription Errors and Transitions of Care
Jeremy M. Kahn, MD, MS; Derek C. Angus, MD, MPH
JAMA. 2011;306(8):878-879. doi:10.1001/jama.2011.1209.
Health Agencies Update |  July 27, 2011
Drug Name Confusion
Tracy Hampton, PhD
JAMA. 2011;306(4):366. doi:10.1001/jama.2011.1012.
Capitol Health Call |  September 08, 2010
Improving Drug Safety
Mike Mitka
JAMA. 2010;304(10):1060. doi:10.1001/jama.2010.1284.
Medical News & Perspectives |  December 02, 2009
FDA Initiative Aims to Reduce Medication-Related Errors
Bridget M. Kuehn
JAMA. 2009;302(21):2304. doi:10.1001/jama.2009.1759.
Commentary |  August 19, 2009
Registries for Robust Evidence
Nancy A. Dreyer, PhD; Sarah Garner, PhD
JAMA. 2009;302(7):790-791. doi:10.1001/jama.2009.1092.
Medical News & Perspectives |  June 10, 2009
FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products
Bridget M. Kuehn
JAMA. 2009;301(22):2316. doi:10.1001/jama.2009.780.
Medical News & Perspectives |  February 11, 2009
Joint Commission Offers Warnings, Advice on Adopting New Health Care IT Systems
Mike Mitka
JAMA. 2009;301(6):587-589. doi:10.1001/jama.2009.37.
Health Agencies Update |  November 26, 2008
Drug Safety
Bridget M. Kuehn
JAMA. 2008;300(20):2359. doi:10.1001/jama.2008.644.
Medical News & Perspectives |  November 19, 2008
New e-Prescribing Guide Unveiled
Bridget M. Kuehn
JAMA. 2008;300(19):2235. doi:10.1001/jama.2008.631.
Original Contribution |  October 22, 2008 FREE
Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union
JAMA. 2008;300(16):1887-1896. doi:10.1001/jama.300.16.1887.
Commentary |  May 14, 2008
Barcoded Medication Administration:  A Last Line of Defense
David W. Cescon, MD; Edward Etchells, MD, MSc
JAMA. 2008;299(18):2200-2202. doi:10.1001/jama.299.18.2200.
Capitol Health Call |  March 12, 2008
Subpoenas Refused
Mike Mitka
JAMA. 2008;299(10):1124. doi:10.1001/jama.299.10.1124-c.
Commentary |  November 14, 2007
Congress Responds to the IOM Drug Safety Report—In Full
Bruce M. Psaty, MD, PhD; David Korn, MD
JAMA. 2007;298(18):2185-2187. doi:10.1001/jama.298.18.2185.
Capitol Health Call |  June 13, 2007
Drug Importation Thwarted
JAMA. 2007;297(22):2465. doi:10.1001/jama.297.22.2465-a.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Dermatology
Research Letters  |  April 01, 2013
Retrospective Review of Adverse Effects From Propranolol in Infants
Eun-Kyung M. Kwon, BA; Shawna Joachim, BA; Dawn H. Siegel, MD; et al.
JAMA Dermatology
Practice Gaps  |  April 01, 2013
Propranolol to Treat Hemangiomas of Infancy:  Safety and Side Effect Recognition
Comment on “Retrospective Review of Adverse Effects from Propranolol in Infants”
Jonathan A. Dyer, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems